Market news — every asset we track

Assets

ARKG

The transactions extend a recent pattern of ARK increasing its exposure to Nvidia while selectively reducing its AMD holdings.

Aug 18Yahoo FinanceARKG

Jul 28Seeking AlphaARKG

Ionis Pharmaceuticals' shares are down more than 27% so far this year. What does Cathie Wood see that others are missing?

Jul 18The Motley FoolARKG

Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.

Jul 14The Motley FoolARKG

Cathie Wood's biotech ETF has largely moved on from the vaccine maker.

Jul 14The Motley FoolARKG

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

Jul 10The Motley FoolARKG BBH IBB

This is the newest page. Registered accounts read further back.